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The Impact of Transcatheter Aortic Valve Implantation on Quality of Life: 
A Mixed Methods Study
Themes & Categories are shown 
in Figure 1. Quantitative  data 
supported interview findings  
with gradual improvements in 
mean EQ-5D scores and SF-36 
physical and mental component 
scores at 1 and 3 months 
compared to baseline. 
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Purpose
TAVI is considered to be the gold 
standard of care for inoperable 
patients diagnosed with severe 
symptomatic acquired aortic 
stenosis. Little in known about 
patients’ views concerning  how
TAVI impacts on QoL during early 
recovery. 
Methods
Mixed methods study design 
(QUAL-quant). Data from in-depth 
interviews with 43 subjects (39% 
male; mean age 81.7 years) at 1 & 
3 months post-TAVI, from a 
regional UK centre, were analyses 
using framework method. QoL 
data (SF-36 and EQ5D) were 
collected concurrently before, 1 & 
3 months post TAVI. Quantitative 
data were analysed using ANOVA.
Results
Shortened Life
Facing Mortality: ‘My son said can my 
Dad have his operation next year, and 
they said no. What happens if I don’t 
have it? He’d be dead within a year'. 
(M,88 yrs, NYHA III).
Deciding to have TAVI: ‘The quality of 
life I had was so poor by that time it was 
well worth the risk’ (F,91, NYHA IV)
Limited  Life
Symptom burden: ‘It was pretty drastic 
really. I couldn’t breathe. I could only 
walk a few yards, I couldn’t breathe at 
all’. (F,87 yrs, NYHA III).
Functional and social restrictions: ‘Some 
days I wished it was all over, I really did, 
because it was so painful to breathe and 
well, your life isn't the same, you can’t 
get out, can’t go shopping or anything’ 
(F,84 yrs, NYHA III).
Extended Life
Survival: ‘I’m just thankful its over 
and done with and there is a light 
at the end of the tunnel where 
there wasn't before’ (F, 86 yrs 
NYHA III). ‘I’ve got maybe a few 
more years to live’ (M, 87 yrs, 
NYHA III).
Changed Life
Symptomatic relief: ‘Well I knew I 
was feeling better because I aren’t 
breathless (F, 86 yrs, NYHA III). ‘I 
do exactly what I used to do ten 
years ago. (M, 85 yrs, NYHA II).
Feeling Safe and Secure: ‘I want to 
feel as though I can do what I 
want, go where I want, not 
bother, not worry about anything, 
you know like chest pains or 
anything like that’ (M, 82 yrs 
NYHA III). 
Conclusion
Figure 1. Themes/categories 
TAVI had an impact on QoL in 
two ways. From a psychological 
perspective recipients had 
confidence that they no longer 
faced imminent death and that 
TAVI had extended their life. 
Most recipients experienced 
relief of physical symptoms 
enabling them to live fuller 
lives.  Self-reported QoL 
improved in 70% of participants 
3-months post TAVI
compared to baseline.  
